Sunshine Act Meeting, 66668 [2019-26346]

Download as PDF 66668 Federal Register / Vol. 84, No. 234 / Thursday, December 5, 2019 / Notices Federal Communications Commission. Marilyn Jones, Senior Counsel for Number Administration, Wireline Competition Bureau. [FR Doc. 2019–26277 Filed 12–4–19; 8:45 am] BILLING CODE 6712–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meeting Thursday, December 12, 2019 at 10:00 a.m. PLACE: 1050 First Street NE, Washington, DC (12th Floor). STATUS: The December 12, 2019 Open Meeting has been canceled. CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. Individuals who plan to attend and require special assistance, such as sign language interpretation or other reasonable accommodations, should contact Laura E. Sinram, Acting Secretary and Clerk, at (202) 694–1040, at least 72 hours prior to the meeting date. TIME AND DATE: Authority: Government in the Sunshine Act, 5 U.S.C. 552b. Laura E. Sinram, Acting Secretary and Clerk of the Commission. [FR Doc. 2019–26346 Filed 12–3–19; 4:15 pm] FEDERAL MARITIME COMMISSION Notice of Agreements Filed The Commission hereby gives notice of the filing of the following agreement under the Shipping Act of 1984. Interested parties may submit comments on the agreements to the Secretary by email at Secretary@fmc.gov, or by mail, Federal Maritime Commission, Washington, DC 20573, within twelve days of the date this notice appears in the Federal Register. Copies of agreements are available through the Commission’s website (www.fmc.gov) or by contacting the Office of Agreements at (202) 523–5793 or tradeanalysis@ fmc.gov. Agreement No.: 201325. Agreement Name: Sealand/Network Space Charter Agreement. Parties: Maersk A/S d/b/a Sealand and Network Shipping, Ltd. Filing Party: Wayne Rohde; Cozen O’Connor. Synopsis: The Agreement authorizes Sealand to charter space to Network Shipping in the trade between ports in Ecuador, Panama, Costa Rica, El Salvador, Guatemala, Nicaragua, and Mexico on the one hand and ports in California on the other hand. Proposed Effective Date: 1/11/2020. Location: https://www2.fmc.gov/ FMC.Agreements.Web/Public/ AgreementHistory/25450. Dated: December 2, 2019. JoAnne O’Bryant, Program Analyst. BILLING CODE 6715–01–P FEDERAL ELECTION COMMISSION [FR Doc. 2019–26262 Filed 12–4–19; 8:45 am] BILLING CODE 6731–AA–P Sunshine Act Meeting Thursday, December 5, 2019 at 10:00 a.m. PLACE: 1050 First Street NE, Washington, DC (12th Floor). STATUS: The December 5, 2019 Open Meeting has been canceled. TIME AND DATE: CONTACT PERSON FOR MORE INFORMATION: jbell on DSKJLSW7X2PROD with NOTICES Judith Ingram, Press Officer, Telephone: (202) 694–1220. Individuals who plan to attend and require special assistance, such as sign language interpretation or other reasonable accommodations, should contact Laura E. Sinram, Acting Secretary and Clerk, at (202) 694–1040, at least 72 hours prior to the meeting date. Authority: Government in the Sunshine Act, 5 U.S.C. 552b. Laura E. Sinram, Acting Secretary and Clerk of the Commission. [FR Doc. 2019–26348 Filed 12–3–19; 4:15 pm] BILLING CODE 6715–01–P VerDate Sep<11>2014 17:38 Dec 04, 2019 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2018–N–3179] Request for Nominations on Public Advisory Panels of the Medical Devices Advisory Committee AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is requesting that any industry organizations interested in participating in the selection of nonvoting industry representatives to serve on certain panels of the Medical Devices Advisory Committee (MDAC or Committee) in the Center for Devices and Radiological Health (CDRH) notify FDA in writing. FDA is also requesting nominations for nonvoting industry SUMMARY: PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 representatives to serve on certain device panels of the MDAC in the CDRH. A nominee may either be selfnominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current and upcoming vacancies effective with this notice. DATES: Any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests must send a letter stating that interest to FDA by January 6, 2020 (see sections I and II of this document for further details). Concurrently, nomination materials for prospective candidates should be sent to FDA by January 6, 2020. ADDRESSES: All statements of interest from industry organizations interested in participating in the selection process of nonvoting industry representative nomination should be sent to Margaret Ames (see FOR FURTHER INFORMATION CONTACT). All nominations for nonvoting industry representatives should be submitted electronically by accessing the FDA Advisory Committee Membership Nomination Portal: https:// www.accessdata.fda.gov/scripts/ FACTRSPortal/FACTRS/index.cfm or by mail to Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993–0002. Information about becoming a member of an FDA advisory committee can also be obtained by visiting FDA’s website at https:// www.fda.gov/AdvisoryCommittees/ default.htm. FOR FURTHER INFORMATION CONTACT: Margaret Ames, Division of Management Services, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5213, Silver Spring, MD 20993, 301–796– 5960, Fax: 301–847–8505, email: margaret.ames@fda.hhs.gov. SUPPLEMENTARY INFORMATION: The Agency is requesting nominations for nonvoting industry representatives to the panels listed in the table in this document. I. Medical Devices Advisory Committee The Committee reviews and evaluates data on the safety and effectiveness of marketed and investigational devices and makes recommendations for their regulation. The panels engage in a number of activities to fulfill the functions that the Federal Food, Drug, and Cosmetic Act (FD&C Act) envisions for device advisory panels. With the E:\FR\FM\05DEN1.SGM 05DEN1

Agencies

[Federal Register Volume 84, Number 234 (Thursday, December 5, 2019)]
[Notices]
[Page 66668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26346]


=======================================================================
-----------------------------------------------------------------------

FEDERAL ELECTION COMMISSION


Sunshine Act Meeting

TIME AND DATE: Thursday, December 12, 2019 at 10:00 a.m.

PLACE: 1050 First Street NE, Washington, DC (12th Floor).

STATUS: The December 12, 2019 Open Meeting has been canceled.

CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, 
Telephone: (202) 694-1220.
    Individuals who plan to attend and require special assistance, such 
as sign language interpretation or other reasonable accommodations, 
should contact Laura E. Sinram, Acting Secretary and Clerk, at (202) 
694-1040, at least 72 hours prior to the meeting date.

    Authority: Government in the Sunshine Act, 5 U.S.C. 552b.

Laura E. Sinram,
Acting Secretary and Clerk of the Commission.
[FR Doc. 2019-26346 Filed 12-3-19; 4:15 pm]
BILLING CODE 6715-01-P